Monthly Prescribing Reference4h
FDA Extends Review of CNTF Ocular Implant for Macular Telangiectasia
NT-501 is an investigational ocular implant that utilizes an encapsulated cell-based delivery system to deliver continuous ciliary neurotrophic factor.
Indy 100 on MSN5h
FDA issue order against common ingredient found in cold and flu medicine
The US Food and Drug Administration (FDA) has proposed an order to ban a popular ingredient in cold and flu medicines as it is seemingly not as effective as other methods. Oral phenylephrine is often ...
Wave Life Sciences treatment of Huntington’s disease gets FDA orphan designation
According to a post on the FDA’s website, Wave Life Sciences (WVE)’ treatment of Huntington’s disease received orphan ...
Health on MSN3d
FDA Plans to Ban Ineffective Cold Medicine Ingredient—How It Will Affect You
The FDA has proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold medications.Last year, an FDA advisory committee concluded that the oral ...
Live Science4d
LED device treats leading cause of vision loss with light therapy, FDA says
The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.